Evans A, Davies M, Osborne V, Roy D, et al. Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study. PLoS One 2020;15:e0240489.
PMID: 33035259